These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development. Jondal M, Gunven P. Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292 [Abstract] [Full Text] [Related]
5. Characterization of Epstein-Barr virus (EBV) antigens II. Detection of early antigen (S) using anticomplement immunofluorescence (ACIF) et complement fixation (CF) tests. Lenoir G, Berthelon MC, Favre MC, De-Thé G. Biomedicine; 1975 Dec 20; 23(10):461-4. PubMed ID: 177116 [Abstract] [Full Text] [Related]
6. The Epstein-Barr virus (EBV) in human pathology. Results of a serological investigation of a hospital population. Dalens M, Didier J, Pris J, Enjalbert L. Biomedicine; 1973 Jul 20; 18(4):336-45. PubMed ID: 4139980 [No Abstract] [Full Text] [Related]
10. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus. Svedmyr A, Demissie A, Klein G, Clifford P. J Natl Cancer Inst; 1970 Mar 20; 44(3):595-610. PubMed ID: 11515428 [No Abstract] [Full Text] [Related]
11. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. Marchini B, Dolcher MP, Sabbatini A, Klein G, Migliorini P. J Autoimmun; 1994 Apr 20; 7(2):179-91. PubMed ID: 7518683 [Abstract] [Full Text] [Related]
13. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT, Fernandes BJ, Mock D. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug 20; 92(2):184-93. PubMed ID: 11505266 [Abstract] [Full Text] [Related]
15. Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies. Reedman BM, Klein G, Pope JH, Walters MK, Hilgers J, Singh S, Johansson B. Int J Cancer; 1974 Jun 15; 13(6):755-63. PubMed ID: 4136722 [No Abstract] [Full Text] [Related]
17. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. Meij P, Vervoort MB, Aarbiou J, van Dissel P, Brink A, Bloemena E, Meijer CJ, Middeldorp JM. J Infect Dis; 1999 May 15; 179(5):1108-15. PubMed ID: 10191211 [Abstract] [Full Text] [Related]
18. The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment. Gunvén P. Hamatol Bluttransfus; 1974 May 15; 14():129-32. PubMed ID: 4375070 [No Abstract] [Full Text] [Related]
20. Purification of soluble complement-fixing antigens from two Burkitt's lymphoma cell lines. Conditions affecting the stability and recovery of antigens and antibodies. Weliky N, Leaman DH, Kallman BJ. Immunology; 1975 Oct 15; 29(4):779-90. PubMed ID: 241721 [Abstract] [Full Text] [Related] Page: [Next] [New Search]